Federal guidelines for prophylactic ICD therapy in high risk populations for sudden cardiac death: Is this a necessary course correction?

Journal of Interventional Cardiac Electrophysiology

Volumn 12, Issue 1, 2005, Pages 5-7

  Saksena, Sanjeev ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOMYOPATHY; CARDIOVASCULAR RISK; DATA ANALYSIS; DEFIBRILLATOR; DISEASE SEVERITY; EDITORIAL; FOLLOW UP; GOVERNMENT REGULATION; HEALTH CARE POLICY; HEALTH PROGRAM; HEART DISEASE; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE CONTRACTION; HEART VENTRICLE TACHYCARDIA; HIGH RISK POPULATION; HOSPITAL; MEDICAL DECISION MAKING; MEDICAL PRACTICE; MEDICARE; MORTALITY; OUTCOMES RESEARCH; PATIENT SELECTION; PHYSICIAN; POPULATION; POPULATION RESEARCH; PRACTICE GUIDELINE; PRIMARY PREVENTION; PRIORITY JOURNAL; PROPHYLAXIS; QRS COMPLEX; RISK REDUCTION; STANDARDIZATION; STATISTICAL ANALYSIS; SUDDEN DEATH; SURVIVAL;

CLINICAL TRIALS; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; FEMALE; GUIDELINES; HUMANS; MALE; MEDICARE; UNITED STATES;

EID: 17644406042     PISSN: 1383875X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10840-005-5834-1     Document Type: Editorial

References (17)

1. Medicare Draft Decision Memo for Implantable Defibrillators (CAG-00157R2) Sept. 28, 2004.
2. Axtell K, Tchou P, Akhtar M. Survival in patients with depressed left ventricular function treated by implantable cardioverter defibrillator. Pacing Clin Electrophysiol 1991; 14(2 Pt 2):291-296.
3. Mehta D, Saksena S, Krol RB. Survival of implantable cardioverter- defibrillator recipients: Role of left ventricular function and its relationship to device use. Am Heart J 1992;124:1608-1614.
4. Domanski MJ, Saksena S, Epstein AE, Hallstrom AP, Brodsky MA, Kim S, Lancaster S, Schron E for the AVID investigators: Relative effectiveness of the implantable cardioverter-defibrillator and antiarrhythmic drugs in patients with varying degrees of left ventricular dysfunction who have survived malignant ventricular arrhythmias. J Am Coll Cardiol 1999;34:1090-1095.
5. AVID Investigators. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med 1997;337:1576-1583.
6. Bardy GH. SCD-HeFT: The Sudden Cardiac Death in Heart Failure Trial. ACC meeting, 2004. http://www. acc04online.org/ondemand/trials1/sessions.asp?link=R
7. Bansch D, Antz M, Boczor S, Volkmer M, Tebbenjohanns J, Seidl K, Block M, Gietzen F, Berger J, Kuck KH. Primary prevention of sudden cardiac death in idiopathic dilated cardiomyopathy: The Cardiomyopathy Trial (CAT). Circulation 2002;105:1453-1458.
8. Bigger JT for the (for the Coronary Artery Bypass Graft (CABG) Patch Trial Investigators). Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronary artery bypass graft surgery. N Engl J Med 1997;337:1569-1575.
9. Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA, De Marco T, Carson P, DiCarlo L, DeMets D, White BG, De Vries DW, Feldman AM; Comparison of Medical Therapy, Pacing and Defibrillation in Heart Failure (COMPANION) Investigators. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 2004;350:2140-2150.
10. Moss AJ, Hall WJ, Cannom DS, Daubert P, Higgins SL, Klein H, Levine JH, Saksena S, Waldo AL, Wilber D, Brown MW, Heo M. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. N Engl Med 1996;335:1933-1940.
11. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, Daubert JP, Higgins SL, Brown MW, Andrews ML, Multicenter Automatic Defibrillator Implantation Trial II Investigators. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002;346:877-883.
12. Strickberger SA, Hummel JD, Bartlett TG, Frumin HI, Schuger CD, Beau SL, Bitar C, Morady F, AMIOVIRT Investigators. Amiodarone versus implantable cardioverter-defibrillator: Randomized trial in patients with non-ischemic dilated cardiomyopathy and Asymptomatic nonsustained ventricular tachycardia - AMIOVIRT. J Am Coll Cardiol 2003;41:1707-1712.
13. Saksena S. Bundle branch block and cardiac resynchronization therapy: Do we need to look further before we leap? J Intervent Card Electrophysiol 2003;8:163.
14. Nudell BM. Medical devices: QRS risk stratification & bang for the buck. Sanford C. Bernstein & Co., LLC Research Call, (05/24/2004).
15. Nudell BM. Cost per life year saved for low risk ICD populations; consequences for European adoption. Sanford C. Berstein & Co., LLC Research Call, (09/14/2004).
16. Rudolph F. Evonich, Alok Maheshwari, Joseph C. Gardiner, Atul Khasnis, Sricharan Kantipudi, John H. Ip, Denise Grimes, Gregory Hayter, Ranjan K. Thakur. Implantable cardioverter Defibrillator therapy in patients with ischemic or non-ischemic cardiomyopathy and nonsustained ventricular tachycardia. J Intervent Cardiol Electrophysiol 2004;11:59.
17. Schoenfeld MH for the NASPE Task Force on the Implementation of an Arrhythmia Device/Lead Database: NASPE Policy Statement: Recommendations for implementation of a North American Multicenter Arrhythmia Device/Lead Database. PACE 1992;15:1632-1636.